Tech Company Financing Transactions
AzureCell Therapies Funding Round
AzureCell Therapies secured a $180 thousand funding round on 7/15/2025. Investors included Venture Kick.
Transaction Overview
Company Name
Announced On
7/15/2025
Transaction Type
Venture Equity
Amount
$180,000
Round
Undisclosed
Investors
Proceeds Purpose
The funds will boost its production platform, support good manufacturing practice (GMP) transition, and cover core business setup, including brand and IT development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Lausanne, Undisclosed
Switzerland
Lausanne, Undisclosed
Switzerland
Phone
Undisclosed
Email Address
Not Recorded
Overview
AzureCell is an award-winning biotech spin-off from the University of Geneva, advancing next-generation regenerative cell therapies for Parkinson's disease and other neurodegenerative disorders. By integrating cutting-edge stem cell technologies with proprietary cell and genetic engineering platforms, we're developing scalable, safe, and effective therapies that address the root cause of neurodegeneration.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bilal Fares
Chief Scientific Officer
Karl-Heinz Krause
Browse more venture capital transactions:
Prev: 7/15/2025: Shopoff Realty Investments venture capital transaction
Next: 7/15/2025: Datavations venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs